Vaccae is lyophilized heat-killed Mycobacterium vaccae vaccine for injection indicated for treatment of patients with pulmonary tuberculosis. Vaccae was co-developed by National Institute for the Control of Drugs and Biological Products, 309 Hospital of PLA, and Anhui Longcom Biologic Pharmacy Co., Ltd.. SFDA of China approved Vaccae in January 2001. (Licence code, GuoYaoZhunZi S20010003)
Company Profile
-
Factory Location669 Changjiang Road (West)
-
Established in2000
-
Business types
- OEM Manufacturer
-
Markets
-
East Asia / Southeast Asia / China / Hong Kong